VP, Sales & Business Development – Diagnostic & Telehealth Services (DxS/Enterprise)

Everlywell is a digital health company pioneering the next generation of biomarker intelligence—combining AI-powered technology with human insight to deliver personalized, actionable health answers. We transform complex biomarker data into life-changing insights—seamlessly integrating advanced diagnostics, virtual care, and patient engagement to reshape how and where health happens. Over the past decade, Everlywell has delivered close to 1 billion personalized health insights, transforming care for 60 million people and powering hundreds of enterprise partners. In 2025, an estimated 1 in 94 U.S. adults received an Everlywell test, solidifying our spot as the #1 at-home testing company in the country. Fueled by AI and built for scale, we’re breaking down barriers, closing care gaps, and unlocking a more connected healthcare experience that is smarter, faster, and more personalized. About DxS DxS is Everlywell’s diagnostics services business that powers diagnostics‑driven programs for external partners. We work with diagnostic laboratories, telehealth and digital health platforms, life sciences and biopharma companies, and other enterprise clients to design and operate programs that use Everlywell’s clinical, operational, and technology infrastructure. Our ambition is to make Everlywell the go‑to commercialization and clinical operations partner for advanced diagnostics—helping innovators bring new tests to market, integrate telehealth and clinical services, and scale high‑quality programs across thousands of patients and multiple channels. Role Summary We are hiring a VP, Sales & Business Development – Diagnostic & Telehealth Services (DxS) to lead the B2B2C commercial motion for Everlywell’s diagnostics services portfolio. You will build and manage a proactive pipeline of consumer‑facing diagnostics brands,DTC digital-health companies, genetics companies with a consumer offering, virtual care providers, and innovative labs that can leverage Everlywell’s infrastructure to launch and scale diagnostics‑driven programs. Rather than selling standalone tests, you will sell the clinical infrastructure underpinning programs across diagnostics, virtual care, logistics/operations, and reporting into partner‑branded or white‑label experiences. You will own the full DxS sales lifecycle—from prospecting and discovery through solution design, commercial modeling, contracting, and handoff to implementation—while partnering closely with Clinical Operations, Product, Finance, and Marketing to shape offerings and ensure programs are set up to scale. This is both a strategic and tactical role: you will help define the future of the DxS business while also carrying a quota and closing net‑new, multi‑stakeholder deals.